3/4
08:56 am
kytx
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $44.00 price target on the stock.
Low
Report
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $44.00 price target on the stock.
3/4
08:06 am
kytx
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $40.00 price target on the stock.
Low
Report
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $40.00 price target on the stock.
3/4
08:06 am
kytx
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $40.00 price target on the stock.
Low
Report
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $40.00 price target on the stock.
3/4
08:06 am
kytx
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $39.00 price target on the stock.
Low
Report
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $39.00 price target on the stock.
3/4
06:23 am
kytx
Rating for KYTX
Medium
Report
Rating for KYTX
3/4
06:07 am
kytx
Rating for KYTX
Medium
Report
Rating for KYTX
3/4
06:07 am
kytx
Rating for KYTX
Medium
Report
Rating for KYTX